Revna Biosciences

Advancing Precision Medicine for All. With an operational base in Accra, Ghana, and serving across West Africa, Revna Biosciences (RevnaBio) is at the forefront of precision medicine, driving innovations in molecular diagnostics, clinical research, and therapeutic discovery. Our mission is simple yet profound: to champion precision medicine for all. We are committed to uncovering the biological foundations of diseases affecting Africans, people of African descent, and the global population. RevnaBio offers a comprehensive suite of specialized biomedical services, including: ☑ Advanced molecular diagnostics ☑ Biobanking and biomarker discovery ☑ Clinical research and central lab services ☑ Disease monitoring and treatment selection ☑ Clinical trial management Through strategic partnerships with global biotech leaders—including QIAGEN, Diatech Pharmacogenetics, ABL Diagnostics, and Idil Biotech—we deliver cutting-edge biomedical solutions in the heart of West Africa. RevnaBio operates with full regulatory approvals and certifications, including: ✔ HeFRA tertiary laboratory permit ✔ Ghana FDA approval ✔ Dual ISO accreditations (ISO 15189:2022; ISO 20387:2018) by the American Association of Laboratory Accreditations (A2LA) ✔ Membership in ISBER (International Society of Biological and Environmental Repositories) Discover how Revna Biosciences is shaping the future of precision medicine. Contact us at +233-59-900-9977 or visit www.revnabio.com